Danhua Chemical Technology (600844.SH) forecasts a preloss, with an expected net loss of 307 million yuan for the year 2024.
Danhua Technology (600844.SH) released a profit warning announcement for the 2024 fiscal year, anticipating a net loss for the year.
Danhua Chemical Technology (600844.SH) has announced a forecast of a net loss of 3.07 billion yuan for the fiscal year 2024, compared to the previous year where they continued to incur losses.
The company's production and operation activities for the current year have remained stable, with product sales similar to the previous year. Preliminary statistics show that the main product, ethylene glycol, had a production of 133,000 tons and sales of 127,300 tons, with a 12.69% increase in the average annual sales price. The second product, oxalic acid, had a production of 99,300 tons and sales of 97,700 tons, with a 19.28% decrease in the average annual sales price. Ethylene glycol prices saw a slight increase during the reporting period, but oxalic acid prices decreased, resulting in overall low product prices.
Related Articles

FedEx Corporation (FDX.US) faced a downgrade from Evercore on the eve of its financial report, warning that demand headwinds could suppress earnings per share.

J&T EXPRESS-W (01519) spent 7.8348 million Hong Kong dollars on repurchasing 870,000 shares on September 17th.

Astrazeneca PLC Sponsored ADR (AZN.US) has submitted an application for the listing of the asthma triple therapy "Bevespi Aerosphere" in China.
FedEx Corporation (FDX.US) faced a downgrade from Evercore on the eve of its financial report, warning that demand headwinds could suppress earnings per share.

J&T EXPRESS-W (01519) spent 7.8348 million Hong Kong dollars on repurchasing 870,000 shares on September 17th.

Astrazeneca PLC Sponsored ADR (AZN.US) has submitted an application for the listing of the asthma triple therapy "Bevespi Aerosphere" in China.
